Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CREBBP | Q92793 | 13/20 | 0.42 |
| ▸ | BRD4 | O60885 | 4/20 | 0.36 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.36 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.34 |
| ▸ | USP1 | O94782 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31489258 | 1.00 | CREBBP (0.42) | CREBBPBRD4GPR55CYP17A1ALDH1A1 | |
| SCHEMBL31489459 | 0.85 | CREBBP (0.42) | CREBBPBRD4GPR55CYP17A1 | |
| SCHEMBL31489380 | 0.85 | CREBBP (0.40) | CREBBPGPR55CYP17A1RIPK1 | |
| SCHEMBL31489470 | 0.85 | CREBBP (0.40) | CREBBPGPR55CYP17A1RIPK1 | |
| SCHEMBL31489526 | 0.85 | CREBBP (0.42) | CREBBPBRD4GPR55CYP17A1 | |
| SCHEMBL31489183 | 0.84 | JAK2 (0.39) | CYP17A1 | |
| SCHEMBL31489249 | 0.84 | JAK2 (0.39) | CYP17A1 | |
| SCHEMBL31489349 | 0.83 | GABRA1 (0.32) | — | |
| SCHEMBL31489575 | 0.83 | GABRA1 (0.32) | — | |
| SCHEMBL26529057 | 0.81 | KDM5B (0.44) | CREBBPBRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025072395-A1 | TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-04-03 | — | — | WO | disclosed |